You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Researchers have developed a spit-based miRNA test to gauge concussion duration in children, NPR reports.
After a 54 percent quarter over quarter rise in sales of the test, Rosetta's CEO said that the realigned strategy will take the firm to profit more quickly.
The company said that given recent debt restructuring efforts and certain regulatory and payor approvals of its products, it's on track for a strong 2017.
In Nucleic Acids Research this week: isomiR-based cancer classifier, map of VjbR binding in Brucella, and more.
The developers said such a signature could help triage people exposed to radiation through war, a terrorist attack, or an industrial accident.
In Science this week: DNA Fountain for storing data in DNA, and more.
The collaborators are developing tests for rectal cancer based on microRNA and messenger RNA signatures.
In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.
Investigators explored computational strategies for identifying microRNAs that are most relevant to tumor development and progression.
In PLOS this week: ramifications of multi-nucleotide de novo mutations, circulating microRNAs and atrial fibrillation, and more.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.